A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma
Devalingam Mahalingam, Christos Fountzilas, Jennifer Moseley, Nicole Noronha, Hue Tran, Romit Chakrabarty, Giovanni Selvaggi, Matthew Coffey, Brad Thompson, John Sarantopoulos
Fingerprint
Dive into the research topics of 'A phase II study of REOLYSIN<sup>®</sup> (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma'. Together they form a unique fingerprint.